| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/19/1995 | EP0648843A1 DNA encoding a hyperthermostable alpha-amylase |
| 04/19/1995 | EP0648842A2 Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof |
| 04/19/1995 | EP0648841A2 Genomic DNA of human Cholesterol 7alpha-hydroxylase and methods for using it |
| 04/19/1995 | EP0648840A2 Cholesterol 7alpha-hydroxylase gene regulatory elements and transcription factors |
| 04/19/1995 | EP0648839A1 Bibenzylsynthase gene |
| 04/19/1995 | EP0648838A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) |
| 04/19/1995 | EP0648837A1 Porcine vasoactive intestinal peptide receptor |
| 04/19/1995 | EP0648836A1 MHC class II transactivator (CIITA) and uses thereof |
| 04/19/1995 | EP0648783A1 TNF inhibitors |
| 04/19/1995 | EP0648777A1 Fluorinated surfaces useful for DNA purification by solid phase extraction |
| 04/19/1995 | EP0648776A1 Surface materials useful for DNA purification by solid phase extraction |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648280A1 Method and reagent for determining specific nucleotide variations |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648271A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648267A1 Expression of polypeptides in e.coli under control of the e.coli mdh-gene promoter |
| 04/19/1995 | EP0648266A1 Elicitor of the hypersensitive response in plants |
| 04/19/1995 | EP0648265A1 Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
| 04/19/1995 | EP0648264A1 Bandage for continuous application of biologicals |
| 04/19/1995 | EP0648263A1 Lipases from hyphozyma |
| 04/19/1995 | EP0648262A1 Dna sequences and plasmids for the preparation of plants with changed sucrose concentration |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648228A1 Bnp antibody and immunoassay using it |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648222A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 04/19/1995 | EP0648219A1 Broad host spectrum rhizobiaceae nodulation signals |
| 04/19/1995 | EP0648128A1 DNA ENCODING PRECURSOR INTERLEUKIN 1$g(b) CONVERTING ENZYME |
| 04/19/1995 | EP0579726A4 Chimeric plant genes based on upstream regulatory elements of helianthinin. |
| 04/19/1995 | EP0531404B1 Ubiquitin-specific protease |
| 04/19/1995 | EP0453458B1 Process for producing a transgenic non-human animal by introduction of exogenous dna in somatic and germ animal cells |
| 04/19/1995 | EP0436016B1 Chimeric anti-cea antibody |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | EP0388466B1 NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME (ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE $i(IN VITRO) DIAGNOSIS OF HIGH BLOOD PRESSURE |
| 04/19/1995 | EP0355147B1 Dna probe specific for pathogenic listeria |
| 04/19/1995 | CN1101674A Isolated DNA sequence which can serve as terminator region in a chimeric gene capable of being used for the transformation of plants |
| 04/19/1995 | CA2108611A1 Manifold valve assembly with removable valve seat |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5408040 Connective tissue growth factor(CTGF) |
| 04/18/1995 | US5408037 Methods for detecting glucagon antagonists |
| 04/18/1995 | US5407957 Production of docosahexaenoic acid by dinoflagellates |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/18/1995 | US5407834 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
| 04/18/1995 | US5407825 Bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 04/18/1995 | US5407824 Recombinant coryneform bacterium for producing L-tryptophan |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407822 Artificial promoter for the expression of proteins in yeast |
| 04/18/1995 | US5407820 Calcium channel α-2 subunit DNAs and cells expressing them |
| 04/18/1995 | US5407819 Genetic engineering |
| 04/18/1995 | US5407813 Using single-stranded target nucleic acid having region of known nucleotide sequence identical to one end of deletion fragment, kits |
| 04/18/1995 | US5407810 Using chaotropic agent to extract exogenous peptide in non-native conformation in phase of polymer and salt |
| 04/18/1995 | US5407803 Method for measuring the activity of angiotensin converting enzyme in biological samples |
| 04/18/1995 | US5407801 Forming linker arm by bisulfite-catalyzed transamination at specific deoxycytidine site; hybridizing duplex to triplex |
| 04/18/1995 | US5407800 Reverse transcription with Thermus thermophilus polymerase |
| 04/18/1995 | US5407798 Amplification of midivariant DNA templates |
| 04/18/1995 | US5407797 Oligonucleotide probes and methods for detecting by hybridization the nucleic acids of bacteria and other living organisms |
| 04/18/1995 | US5407795 CMV probes for use in solution phase sandwich |
| 04/18/1995 | US5407454 Larvicidal lectins and plant insect resistance based thereon |
| 04/18/1995 | CA1335264C Yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts |
| 04/18/1995 | CA1335263C T7 dna polymerase |
| 04/13/1995 | WO1995010034A2 A method for characterizing polymer molecules or the like |
| 04/13/1995 | WO1995009929A1 Detection of amplified or deleted chromosomal regions |
| 04/13/1995 | WO1995009927A2 Assay procedure and application in identification of herbicides |
| 04/13/1995 | WO1995009926A1 Genes encoding resistance to dna alkylating agents |
| 04/13/1995 | WO1995009924A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | WO1995009923A1 Method of producing recombinant eukaryotic viruses in bacteria |
| 04/13/1995 | WO1995009922A1 Cloned pullulanase |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009920A1 Virus resistant or tolerant cells |
| 04/13/1995 | WO1995009919A1 Vaccines and diagnostics for borrelia burgdorferi |
| 04/13/1995 | WO1995009918A1 Tissue inhibitor metalloproteinase type three (timp-3) |
| 04/13/1995 | WO1995009917A1 Genetically engineered bispecific tetravalent antibodies |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009915A1 In vitro method for circular single-stranded dna |
| 04/13/1995 | WO1995009914A1 Multicloning vector, expression vector, and production of foreign protein with expression vector |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009911A1 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 04/13/1995 | WO1995009910A1 Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same |
| 04/13/1995 | WO1995009908A1 Novel tissue plasminogen activator analog |
| 04/13/1995 | WO1995009872A1 Dna encoding prostaglandin receptor ip |
| 04/13/1995 | WO1995009871A1 Novel antitumor peptide |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995007991A3 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 04/13/1995 | WO1995007989A3 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | CA2694798A1 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647715A1 Genetic engineering of novel plant phenotypes |
| 04/12/1995 | EP0647714A1 Peptidyl prolyl-cis.trans-isomerase |